Pediatric coronary artery bypass grafting (PCABG) is performed for critical coronary stenosis. PCABG presents unique surgical challenges for surgeons including the small vessel caliber, small areas of vascular access, and the position and distribution of the coronary vasculature. Serious perioperative complications are common, including arrhythmias, myocardial infarction, and sudden death. To reduce technical complications and improve outcomes, the divisions of Cardiothoracic Surgery and Plastic and Reconstructive Surgery at our centre have collaborated during these procedures, to utilize the expertise of the plastic surgeon in performing microvascular anastomosis. We provide a detailed technical description and report our institutional experience for all patients who have undergone PCABG procedures, separately analyzing how these outcomes compare to patients in which microvascular techniques were used.
RESULTS:
Outcomes were evaluated for a total of 24 patients. The median age was 8.39 years (range, 0.27-16.21 years) and the median weight was 24.2 kg (range, 4.6-71 kg) at operation. Three male and three female patients had microsurgical involvement, comprising the six youngest patients in the cohort, with a median age at operation of 2.01 years (range, 0.27-4.43 years) and a median weight at operation was 10.75 kg (range, 4.6-12.2 kg). Three major anastomotic complications occurred requiring reoperation, although none occurred in the microvascular group. Median follow up was 3.54 years (range, 0.1-12 years) and 5.25 years (range, 1.92-12) for the entire cohort and the microvascular group, respectively. Three patients were symptomatic according to subjective report at last follow-up and two deaths occurred in our series, all in the group without microsurgical involvement. All grafts were patent in both groups. Differences between pre-and post-operative ejection fraction were not statistically different between patients with and without microsurgical involvement.
CONCLUSION:
Our results demonstrate the positive impact of collaboration between cardiac and microvascular surgeons during PCABG procedures, and the subsequent reduction in complications that can be expected. This highlights the broad utility of microsurgical expertise and how these techniques may be used to improve patient outcomes. Larger studies in the future with age-matched controls are required to determine whether microsurgical involvement in PCABG improves outcomes. 
PURPOSE:
Studies have suggested several factors that affect free flap fat necrosis and abdominal morbidity after DIEP flap breast reconstruction. We aimed, by conducting the most inclusive and current multivariate analysis of these factors to date, to clarify how patient specific perforator selection can affect fat necrosis and abdominal morbidity, thus guiding future operative decision-making.
METHODS:
Retrospective review of a prospectively maintained, 866 free-flap database was performed for patients undergoing breast reconstruction at one institution from 2010-2016. 29 potential predictors, including patient demographic factors and intraoperative parameters, were included in a multivariate analysis for outcomes of fat necrosis, abdominal wounds, and abdominal bulge or hernia. These results were reported as Odds Ratios (OR) with 95% Confidence Intervals. Univariate analyses were utilized to confirm that potentially confounding pre-surgical and intraoperative factors amongst each of the three primary outcome variables were sufficiently equivalent. Any wound requiring local wound care after 2 weeks was characterized as a minor abdominal wound, whereas major abdominal wounds were defined as wounds requiring return to the operating room.
RESULTS: 409 total DIEAP flaps were included with an average 18.5-month follow-up: 14.4% had fat necrosis, 21.2% had a minor or major abdominal wound, and 6% had an abdominal bulge or hernia. Analysis showed increased odds of fat necrosis with increasing flap weight (OR 1.002 per 1g increase, p<.001), and earlier year of surgery (OR 2.324 for 2010 (OR 2.324 for -2013 (OR 2.324 for vs. 2014 (OR 2.324 for -2016 , and decreased odds of fat necrosis with lateral or both-row perforators vs. medial row (OR.303, .0229, p-value=.0013), and neoadjuvant chemotherapy (OR.384, p=.016). Perforator flow rate/ caliber and number of perforators did not affect fat necrosis. However, upon subgroup analysis on flaps with fat necrosis, we found that there was a significant difference in weight between single perforator flaps and multi-perforator flaps (789g vs. 983g respectively, p= .048). There was an increased odds of having abdominal wounds with smoking (OR 1.869, p=.02), hypertension (OR 1.720, p=.04), and increasing flap weight (OR 1.001 per 1g increase, p<.01). BMI was not a significant factor for abdominal wounds when controlled by flap weight in the multivariate analysis. Increased odds of abdominal bulge/hernia were seen with a return to the OR same hospital stay (OR 5.922, p<.01), and with lateral/both row perforators vs. medial row (OR 3.01, p=.058).
CONCLUSIONS:
Our analysis of DIEP flaps shows surgeon experience reduced the odds of fat necrosis, while heavier flap weights increased these odds. Moreover, adding lateral row perforators may decrease fat necrosis at the potential cost of increasing abdominal bulges. While perforator number was not a significant predictor of fat necrosis in the multivariate analysis, the subgroup analysis may indicate that there is a higher allowable threshold of flap weight before fat necrosis occurs with multi-perforator versus single perforator DIEP flaps. PURPOSE: Neurotrophic keratopathy (NK) is a degenerative corneal disease that develops in patients with absent corneal sensation and innervation. In the absence of innervation, the corneal epithelium is susceptible to breakdown resulting in persistent corneal ulcerations, scarring and progressive vision loss. In severe cases, patients develop corneal perforation and blindness. Standard ophthalmic therapy fails to address the underlying loss of nerve-derived trophic support, and thus many patients continue to develop vision loss despite optimal ophthalmic management. Clinical studies have suggested that reinnervation of the cornea with corneal neurotization improves corneal sensation, ocular surface health and maintains vision in patients with NK. While promising, clinical studies are limited by the rarity and heterogeneity of NK and the inability to harvest tissue. The purpose of this study was to use a novel rat model of NK and corneal neurotization to determine whether corneal reinnervation prevents breakdown of the corneal epithelium and decreases corneal scarring.
METHODS:
Using a novel rat model of NK, the corneal innervation of the left cornea was ablated in ten rats; five were randomized to receive treatment with corneal neurotization after ablation. Tarsorrhaphy of the left cornea was performed in all rats to protect the corneal surface. Four weeks after ablation, the tarsorrhaphy was removed. Each rat was assessed daily with standardized photographs under normal light and with a Wood's lamp/fluorescein staining to assess corneal scarring and epithelial breakdown respectively. Area of corneal ulceration was analyzed as a percentage of the entire cornea. Data was analyzed using a Fisher's exact test or Student's t test where appropriate.
RESULTS:
Seven days after removal of the tarsorrhaphy and exposure of the left cornea, a significantly larger percentage of the corneal surface in rats without corneal neurotization treatment was ulcerated in comparison to rats
